Esperion Therapeutics (LTS:0IIM) Short-Term Capital Lease Obligation : $2.8 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Esperion Therapeutics Short-Term Capital Lease Obligation?

Esperion Therapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $2.8 Mil.

Esperion Therapeutics's quarterly Short-Term Capital Lease Obligation stayed the same from Sep. 2024 ($2.7 Mil) to Dec. 2024 ($2.7 Mil) but then increased from Dec. 2024 ($2.7 Mil) to Mar. 2025 ($2.8 Mil).

Esperion Therapeutics's annual Short-Term Capital Lease Obligation increased from Dec. 2022 ($0.4 Mil) to Dec. 2023 ($1.6 Mil) and increased from Dec. 2023 ($1.6 Mil) to Dec. 2024 ($2.7 Mil).

Esperion Therapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Esperion Therapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Esperion Therapeutics Short-Term Capital Lease Obligation Chart

Esperion Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.59

1.39

0.38

1.55

2.74

Esperion Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															2.54	2.68	2.74	2.74	2.82

Esperion Therapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Esperion Therapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Esperion Therapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Esperion Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Esperion Therapeutics Inc (LTS:0IIM) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

ESPR:USA 0ET:Germany 0ET:Germany

Address

3891 Ranchero Drive, Suite 150, Ann Arbor, MI, USA, 48108

Website

https://www.esperion.com

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Esperion Therapeutics Headlines

No Headlines